CRI
MGRX icon

Colonial River Investments’s Mangoceuticals MGRX Stock Holding History

Colonial River Investments’s Portfolio MGRX Stock Details MGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,407
Closed -$66.1K – 165
2023
Q2 		$66.1K Buy
+2,407
New +$47.4K 0.04% 167

Other funds holding MGRX

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
DGAM
Desjardins Global Asset Management Montreal, Quebec, Canada $930M AUM 31.76% 1-Year Est. Return
VCWA
Vanguard Capital Wealth Advisors Denver, Colorado $148M AUM 91.21% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
MCG
McCollum Christoferson Group Amherst, New York $341M AUM 15.01% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $9.32B AUM 33.19% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Colonial River Investments's MGRX Position: Q3 2023 in Review

Colonial River Investments sold out of Mangoceuticals (MGRX) in Q3 2023, closing a stake of 2,407 shares — an estimated $66.1K sold.

Colonial River Investments first reported a position in MGRX in Q2 2023 and held it in 1 quarter. The position peaked at $66.1K in Q2 2023. 9 funds tracked by Wall St. Rank hold MGRX as of Q3 2023.

  • Colonial River Investments reported no remaining Mangoceuticals position as of Q3 2023 after selling out during the quarter.
  • Colonial River Investments sold 2,407 Mangoceuticals shares in Q3 2023, an estimated $66.1K.
  • Colonial River Investments first reported a position in Mangoceuticals in Q2 2023 and held it in 1 quarter.
  • Colonial River Investments's Mangoceuticals position peaked at $66.1K in Q2 2023.
  • 9 funds tracked by Wall St. Rank held Mangoceuticals as of Q3 2023.

Based on Colonial River Investments's 13F filing for Q3 2023, filed 3 Nov 2023.